Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Bénédicte, Franck"'
Autor:
Philippe Ovetchkine, Anders Åsberg, Julie Autmizguine, Jean-Baptiste Woillard, Pierre Marquet, Bénédicte Franck, Yves Théorêt
Publikováno v:
Clinical Pharmacokinetics. 60:1449-1462
Given a high pharmacokinetic inter-individual variability and a low exposure target achievement, ganciclovir (GCV) therapeutic drug monitoring is sometimes used in children. We aimed to develop and validate Bayesian estimators based on limited sampli
Autor:
Philippe Ovetchkine, Jean-Baptiste Woillard, Pierre Marquet, Bénédicte Franck, Julie Autmizguine, Anne-Laure Lapeyraque, Yves Théorêt, Emile Demers, Henrique Bittencourt, Annabelle Briand
Publikováno v:
British Journal of Clinical Pharmacology. 87:3105-3114
AIMS Ganciclovir (GCV) and its prodrug valganciclovir (VGCV) are first-line agents to prevent and treat cytomegalovirus in transplant recipients. There is high pharmacokinetic (PK) interindividual variability and PK data are scarce, especially in pae
Autor:
Camille Tron, Florian Lemaitre, Pauline Bros, Claire Goulvestre, Bénédicte Franck, Nicolas Mouton, Sandrine Bagnos, Romain Coriat, Nihel Khoudour, Dorothée Lebert, Benoit Blanchet
Publikováno v:
Bioanalysis
Bioanalysis, 2022, 14 (11), pp.831-844. ⟨10.4155/bio-2022-0057⟩
Bioanalysis, 2022, 14 (11), pp.831-844. ⟨10.4155/bio-2022-0057⟩
International audience; Background: This study compared the performance of plasma infliximab and adalimumab quantification using a commercially available kit (mAbXmise kit) and mass spectrometry readout to that of two ELISA methods in patients treate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac41138b8b9ee91731af73154616ae6f
https://hal.science/hal-03714484
https://hal.science/hal-03714484
Autor:
Xavier Duval, Bénédicte Franck, Matthieu Revest, Camille Tron, Jonathan M. Chemouny, Sébastien Lalanne, Roch Houot, Marie-Clémence Verdier, Florian Lemaitre
Publikováno v:
Clinical Biochemistry
Clinical Biochemistry, 2022, 109-110, pp.86-89. ⟨10.1016/j.clinbiochem.2022.09.003⟩
Clinical Biochemistry, 2022, 109-110, pp.86-89. ⟨10.1016/j.clinbiochem.2022.09.003⟩
International audience; The most appropriate renal function estimation equation to predict drug clearance is a matter of debate. In this study, we compare the Modification of Diet in Renal Disease (MDRD), the Chronic Kidney Disease Epidemiology colla
Autor:
Bénédicte, Franck, Julie, Autmizguine, Anders, Åsberg, Yves, Théorêt, Pierre, Marquet, Philippe, Ovetchkine, Jean-Baptiste, Woillard
Publikováno v:
Clinical pharmacokinetics. 60(11)
Given a high pharmacokinetic inter-individual variability and a low exposure target achievement, ganciclovir (GCV) therapeutic drug monitoring is sometimes used in children. We aimed to develop and validate Bayesian estimators based on limited sampli
Autor:
Jean-Baptiste Woillard, Pierre Marquet, Bénédicte Franck, Julie Autmizguine, Philippe Ovetchkine
Publikováno v:
Clinical pharmacology and therapeutics. 112(2)
Ganciclovir and valganciclovir are first choice drugs for the prevention and treatment of cytomegalovirus infection and disease in solid organ and stem cell transplant recipients. Only a few studies on the pharmacokinetics and exposure/efficacy or ex
Autor:
Hélène Roy, Jean-François Bussières, Philippe Ovetchkine, Denis Lebel, Bénédicte Franck, Lydia R Rahem
Publikováno v:
Can J Hosp Pharm
Background: Antimicrobial stewardship is a standard practice in health facilities to reduce both the misuse of antimicrobials and the risk of resistance. Objective: To determine the profile of antimicrobial use in the pediatric population of a univer
Autor:
Caroline Monchaud, Vincent Allot, Jean-Baptiste Woillard, Julien Allard, Marie Essig, Pierre Marquet, Bénédicte Franck, Jean-Philippe Rerolle, Franck Saint-Marcoux
Publikováno v:
European journal of clinical pharmacology. 76(7)
The usual recommended dose for gentamicin is 3 to 7 mg/kg/day for patients with a normal renal function while 1.7 mg/kg/day is recommended for patients undergoing chronic haemodialysis. The objectives of this study were to develop a population pharma
Autor:
Caroline Monchaud, Pierre Marquet, Souleiman El Balkhi, Bénédicte Franck, S. Dulaurent, Nicolas Picard, Jean-Baptiste Woillard, Sylvain Couderc, Franck Saint-Marcoux
A 67‐year‐old man was admitted to the emergency department about 5 h after deliberate self‐poisoning with 300 mg of Apixaban. The clinical examination did not show any organ dysfunctions or haemorrhagic signs, and the patient's life was not in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72ba9058ada8679a25f3a3ef0f975f0f
https://europepmc.org/articles/PMC6303243/
https://europepmc.org/articles/PMC6303243/